Please use this identifier to cite or link to this item:
Title: Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience
Author: Cordero Coma, Miguel
Calvo Río, Vanesa
Adán Civera, Alfredo
Blanco, Ricardo
Álvarez Castro, Carolina
Mesquida, Marina
Calleja, Sara
González-Gay, Miguel A.
Ruíz de Morales, José G.
Keywords: Uveïtis
Issue Date: 28-May-2014
Publisher: Hindawi Publishing Corporation
Abstract: Objective. To evaluate, in three Spanish tertiary referral centres, the short-term safety and efficacy of golimumab (GLM) for treatment of immune-mediated uveitis resistant to previous immunosuppressive therapy. Methods. Nonrandomized retrospective interventional case series. Thirteen patients with different types of uveitis that were resistant to treatment with at least 2 previous immunosuppressors were included in this study. All included patients were treated with GLM (50 mg every four weeks) during at least 6 months. Clinical evaluation and treatment-related side effects were assessed at least four times in all included patients. Results. Eight men and 5 women (22 affected eyes) with a median age of 30 years (range 20-38) and active immune-mediated uveitides were studied. GLM was used in combination with conventional immunosuppressors in 7 patients (53.8%). GLM therapy achieved complete control of inflammation in 12/13 patients (92.3%) after six months of treatment. There was a statistically significant improvement in mean BCVA (0.60 versus 0.68, P - 0.009) and mean 1 mm central retinal thickness (317 versus 261.2 mu, P -0.05) at the six-month endpoint when compared to basal values. No major systemic adverse effects associated with GLM therapy were observed. Conclusions. GLM is a new and promising therapeutic option for patients with severe and refractory uveitis.
Note: Reproducció del document publicat a:
It is part of: Mediators of Inflammation, 2014, vol. 2014
Related resource:
ISSN: 0962-9351
Appears in Collections:Articles publicats en revistes (Cirurgia i Especialitats Medicoquirúrgiques)

Files in This Item:
File Description SizeFormat 
666315.pdf1.28 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons